Us Remote Therapeutic Monitoring Msk Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 2,350.10 |
 CAGR |
% |
| Major Markets Players |
>美国远程治疗监测 (MSK) 市场，按产品（解决方案软件、服务和硬件）、部署模式（基于云和本地）、访问模式（基于移动和基于网络）、代码（98975、98976、98977、98980 和 98981）、类型（持续监测、主动监测和间歇性监测）、应用（非生理数据和治疗数据）、购买模式（团购和个人）、最终用户（提供商、付款人和患者）、分销渠道（直销和间接销售）划分 - 行业趋势和预测到 2030 年。
美国远程治疗监测 (MSK) 市场分析和规模
这些公司的存在为整个地区的远程治疗监测提供了具有竞争力的价格。由于这些参与者在地区和国际层面的存在，供应商和制造商提供不同规格和特点的产品，适合所有预算。人工智能和机器学习的日益融合推动了市场增长。远程治疗监测需求的不断增长预计将推动市场增长。
Data Bridge Market Research 分析称，美国远程治疗监测 (MSK) 市场预计到 2030 年将达到 23.501 亿美元，预测期内复合年增长率为 18.3%。本市场报告还深入介绍了定价分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）和定价（美元） |
|
涵盖的领域 |
产品（解决方案软件、服务和硬件）、部署模式（基于云和本地）、访问模式（基于移动和基于网络）、代码（98975、98976、98977、98980 和 98981）、类型（持续监测、主动监测和间歇性监测）、应用（非生理数据和治疗数据）、购买模式（团购和个人）、最终用户（提供商、付款人和患者）、分销渠道（直销和间接销售） |
|
覆盖国家 |
我们 |
|
涵盖的市场参与者 |
Zimmer Biomet、Omada Health Inc.、HealthViewX、Propeller Health、Limber Health Inc.、Murata Vios、Owlytics Healthcare、Medistics LLC.、INTELLIH INC.、HealthArc、CIPHER SKIN INC.、Medsien, Inc.、Censon Health 和 Exer Labs, Inc. |
市场定义
美国的远程治疗监测 (RTM) 市场是指医疗保健行业的一部分，专注于使用数字技术远程监测和管理肌肉骨骼 (MSK) 疾病。它包括远程医疗和远程监测工具，为患有 MSK 疾病的个人提供持续的评估、监测和支持，使医疗保健提供者能够远程跟踪和管理患者的肌肉骨骼健康。
在 RTM 市场中，医疗保健提供商利用可穿戴设备、移动应用程序、远程医疗平台和远程监控软件来远程监控 MSK 患者。这些工具可以收集与患者症状、活动能力、锻炼习惯、治疗计划依从性和其他相关参数相关的数据。
美国远程治疗监测 (MSK) 市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
司机
- 不断进步的技术
可穿戴设备、移动应用程序和远程医疗平台等技术的快速进步促进了远程治疗监测。这些技术提供实时数据收集、传输和分析，使医疗保健提供者能够远程监测患者的生命体征、药物依从性和整体健康状况。技术进步推动了可穿戴设备和传感器的发展，可以监测各种 MSK（肌肉骨骼）参数，如运动、姿势、运动范围、肌肉活动和关节压力。这些设备可以收集实时数据并提供客观测量，使医疗保健提供者能够监测患者的 MSK 状况并远程跟踪他们的进展。准确可靠的可穿戴设备增强了对 MSK 状况的远程治疗监测。
例如，
- 2021 年 5 月，据 ScienceDirect 报道，在过去几年中，技术通过引入可穿戴和光学传感器彻底改变了运动捕捉领域，从而能够自动获取可靠准确的运动数据进行生物力学分析，同时关于使用 RGB-D 传感器进行肌肉骨骼健康监测的技术辅助方法的科学文献也得到了发展
人工智能（AI）与机器学习（ML）的融合
AI 和 ML 技术正在被整合到 MSK 疾病的远程治疗监测系统中。这些技术可以分析大型数据集、识别趋势并提供预测分析。AI 驱动的算法可以帮助识别潜在的恶化、预测突发事件并根据个体患者数据个性化治疗计划。集成 AI 和 ML 可提高 MSK 疾病远程治疗监测的准确性和效率。
AI 和 ML 算法可以处理从远程监控设备、可穿戴设备和其他来源收集的大量数据。这些算法可以分析数据模式、趋势和相关性，以识别 MSK 病情、疾病进展和治疗反应的潜在指标。通过从数据中提取有价值的见解，AI 和 ML 使医疗保健提供者能够更准确、更及时地做出决策，从而改善患者护理和治疗结果。
因此，根据上述讨论，人工智能（AI）和机器学习（ML）的融合正在推动预测期内的市场增长。
机会
- 美国远程医疗服务日益扩张
远程医疗服务的扩展和远程会诊的日益普及促进了肌肉骨骼远程治疗监测的发展。远程医疗平台允许医疗保健提供者远程评估患者、提供指导并监测治疗进展，从而提高肌肉骨骼疾病患者的可及性和便利性。
远程医疗使患者能够远程访问医疗服务，从而消除了地理距离和医疗基础设施有限等障碍。随着远程医疗的扩展，无论身在何处，越来越多的患者都可以从远程治疗监测中受益。这种增加的访问量为远程监控公司提供了接触更广泛患者群体和扩展服务的机会。远程医疗平台为医疗保健提供者提供了一种远程实时监控患者的方法。通过视频咨询、安全消息传递和远程监控设备，医疗保健专业人员无需亲自拜访即可监测生命体征、跟踪进展并评估患者状况。远程治疗监测可以无缝集成到远程医疗平台中，从而实现持续监测和个性化护理管理。
例如，
- 2020 年 11 月，根据 NCBI 的数据，政府保险报销政策尤其影响了美国远程医疗的采用
Cision US, Inc. 于 2022 年 11 月开展的研究结果发现，去年超过 90% 的美国人使用了远程医疗服务，并且 90% 的人享受了远程医疗服务。这些服务包括医生预约、远程牙科和视力预约
因此，可以得出结论，远程医疗平台的扩展为预测期内的市场增长提供了机会。
克制/挑战
- 数据安全和隐私问题
远程监控系统中患者健康数据的传输和存储引发了人们对数据安全和隐私的担忧。确保患者信息得到保护并遵守 HIPAA 等法规对于建立信任和鼓励采用远程监控技术至关重要。
数据安全和隐私问题可能导致患者不愿采用远程治疗监测解决方案。如果患者不确定他们的数据将如何受到保护以及谁将有权访问这些数据，他们可能会犹豫是否要分享敏感的健康信息和生物特征数据。对远程监控平台和医疗保健提供商实施的安全措施缺乏信任可能会阻碍患者参与并限制市场增长。
例如，
- 2023 年 1 月，根据 SmartClinix 的说法，远程患者监控 (RPM) 依赖于通过互联网传输敏感医疗数据。因此，安全性是一个重要问题。它容易受到网络攻击、数据泄露和各种威胁。这些威胁可能会损害患者的完整性、可用性和机密性。这可能会给患者和医疗保健提供者带来严重后果
因此，根据上述讨论，数据安全和隐私问题可能会在预测期内抑制市场增长。
- 2022 年 4 月，在对解决方案架构、数据安全、安全实践和运营流程进行全面的独立第三方审核后，INTELLIH INC. 获得了服务组织控制 2 (SOC 2) 认证
- 2021 年 8 月，Zimmer Biomet 和 Canary Medical 宣布获得 FDA De Novo 分类授权，并授权销售世界上第一个智能膝关节植入物 Persona IQ。这有助于该公司加强其产品组合
美国远程治疗监测 (MSK) 市场范围
美国远程治疗监测 (MSK) 市场根据产品、部署模式和访问模式、代码、类型、应用、购买模式、最终用户和分销渠道分为九个值得注意的细分市场。这些细分市场之间的增长将帮助您分析行业中微弱的增长细分市场，并为用户提供有价值的市场概览和见解，帮助他们做出战略决策，以确定核心市场应用。
产品
- 解决方案软件
- 服务
- 硬件
根据产品，美国远程治疗监测 (MSK) 市场分为解决方案软件、服务和硬件。
部署模式
- 基于云
- 本地
根据部署模式，美国远程治疗监测 (MSK) 市场分为基于云和本地部署。
访问方式
- 基于移动设备
- 基于 Web
根据访问模式，美国远程治疗监测 (MSK) 市场分为基于移动端和基于网络的。
代码
- 98975
- 98976
- 98977
- 98980
- 98981
根据代码，美国远程治疗监测 (MSK) 市场细分为 98975、98976、98977、98980 和 98981。
类型
- 持续监控
- 主动监控
- 间歇性监测
根据类型，美国远程治疗监测 (MSK) 市场分为持续监测、主动监测和间歇性监测。
应用
- 非生理数据
- 治疗数据
根据应用，美国远程治疗监测 (MSK) 市场分为非生理数据和治疗数据。
购买方式
- 团购
- 个人
根据购买模式，美国远程治疗监测（MSK）市场分为团购和个人购买。
最终用户
- 提供者
- 付款人
- 病人
根据最终用户，美国远程治疗监测 (MSK) 市场分为提供商、付款人和患者。
分销渠道
- 直销
- 间接销售
根据分销渠道，美国远程治疗监测 (MSK) 市场分为直接销售和间接销售。
竞争格局和美国远程治疗监测 (MSK) 市场份额分析
美国远程治疗监测 (MSK) 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、财务状况、产生的收入、市场潜力、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
美国远程治疗监测 (MSK) 市场的一些主要市场参与者包括 Zimmer Biomet、Omada Health Inc.、HealthViewX、Propeller Health、Limber Health Inc.、Murata Vios、Owlytics Healthcare、Medistics LLC.、INTELLIH INC.、HealthArc、CIPHER SKIN INC.、Medsien, Inc.、Censon Health 和 Exer Labs, Inc.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 INDUSTRY INSIGHTS
5.1 DEMOGRAPHIC TRENDS
5.2 KEY PRICING STRATEGIES
5.3 KEY PATIENT ENROLLMENT STRATEGIES
6 REIMBURSEMENT SCENARIO FOR REMOTE PATIENT MONITORING
7 REGULATORY FRAMEWORK
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISING TECHNOLOGICAL ADVANCEMENTS
8.1.2 INTEGRATION OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML)
8.1.3 GROWING DEMAND FOR HOME HEALTHCARE
8.1.4 INCREASING PREVALENCE OF MUSCULOSKELETAL DISORDERS
8.2 RESTRAINTS
8.2.1 DATA SECURITY AND PRIVACY CONCERNS
8.2.2 HIGH COST ASSOCIATED WITH ELECTRONIC HEALTH RECORD (EHR) SERVICE
8.3 OPPORTUNITIES
8.3.1 GROWING EXPANSION OF TELEHEALTH IN THE U.S.
8.3.2 IMPROVED PATIENT OUTCOMES AND SELF-MANAGEMENT
8.3.3 RISING HEALTHCARE EXPENDITURE
8.4 CHALLENGES
8.4.1 SOFTWARE INCOMPATIBILITY ISSUES DUE TO VARYING DATA STANDARDS
8.4.2 REGULATORY AND LEGAL CHALLENGES
9 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY PRODUCT
9.1 OVERVIEW
9.2 SOLUTIONS SOFTWARE
9.3 SERVICES
9.4 HARDWARE
10 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY DEPLOYMENT MODE
10.1 OVERVIEW
10.2 CLOUD BASED
10.3 ON PREMISES
11 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY MODE OF ACCESS
11.1 OVERVIEW
11.2 MOBILE BASED
11.2.1 ANDROID
11.2.2 IOS
11.3 WEB BASED
12 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY CODES
12.1 OVERVIEW
12.2 98975
12.3 98976
12.4 98977
12.5 98980
12.6 98981
13 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY TYPE
13.1 OVERVIEW
13.2 CONTINUOUS MONITORING
13.3 PROACTIVE MONITORING
13.4 INTERMITTENT MONITORING
14 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 NON PHYSIOLOGICAL DATA
14.3 THERAPEUTIC DATA
14.3.1 THERAPY ADHERENCE
14.3.2 THERAPY RESPONSE
15 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY PURCHASE MODE
15.1 OVERVIEW
15.2 GROUP PURCHASE
15.2.1 SOLUTIONS SOFTWARE
15.2.2 SERVICES
15.2.3 HARDWARE
15.3 INDIVIDUAL
15.3.1 SOLUTIONS SOFTWARE
15.3.2 SERVICES
15.3.3 HARDWARE
16 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY END USERS
16.1 OVERVIEW
16.2 PROVIDERS
16.2.1 HOME HEALTH
16.2.2 HOSPITALS
16.2.3 CLINICS
16.2.4 OTHERS
16.3 PAYERS
16.3.1 PRIVATE
16.3.2 PUBLIC
16.4 PATIENT
17 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 DIRECT SALES
17.3 INDIRECT SALES
18 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: U.S.
19 COMPANY PROFILE
19.1 ZIMMER BIOMET.
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 PRODUCT PORTFOLIO
19.1.4 RECENT DEVELOPMENT
19.2 OMADA HEALTH INC.
19.2.1 COMPANY SNAPSHOT
19.2.2 PRODUCT PORTFOLIO
19.2.3 RECENT DEVELOPMENTS
19.3 HEALTHVIEWX.
19.3.1 COMPANY SNAPSHOT
19.3.2 PRODUCT PORTFOLIO
19.3.3 RECENT DEVELOPMENT
19.4 PROPELLER HEALTH.
19.4.1 COMPANY SNAPSHOT
19.4.2 PRODUCT PORTFOLIO
19.4.3 RECENT DEVELOPMENT
19.5 LIMBER HEALTH, INC.
19.5.1 COMPANY SNAPSHOT
19.5.2 PRODUCT PORTFOLIO
19.5.3 RECENT DEVELOPMENTS
19.6 CENSON HEALTH
19.6.1 COMPANY SNAPSHOT
19.6.2 PRODUCT PORTFOLIO
19.6.3 RECENT DEVELOPMENTS
19.7 CIPHER SKIN INC.
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 EXER LABS, INC
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT DEVELOPMENT
19.9 HEALTHARC
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENTS
19.1 INTELLIH INC.
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENT
19.11 MEDISTICS LLC.
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 MEDSIEN, INC.
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT DEVELOPMENT
19.13 MURATA VIOS.
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 OWLYTICS HEALTHCARE.
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENTS
20 QUESTIONNAIRE
21 RELATED REPORTS
表格列表
TABLE 1 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION)
TABLE 3 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY MODE OF ACCESS, 2021-2030 (USD MILLION)
TABLE 4 U.S. MOBILE BASED IN REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY MODE OF ACCESS, 2021-2030 (USD MILLION)
TABLE 5 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY CODES, 2021-2030 (USD MILLION)
TABLE 6 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 8 U.S. THERAPEUTIC DATA IN REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 9 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 10 U.S. GROUP PURCHASE IN REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 U.S. INDIVIDUAL IN REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 12 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 13 U.S. PROVIDERS IN REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 14 U.S. PAYERS IN REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 15 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: SEGMENTATION
FIGURE 2 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: DATA TRIANGULATION
FIGURE 3 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: DROC ANALYSIS
FIGURE 4 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: SEGMENTATION
FIGURE 11 RISING TECHNOLOGICAL ADVANCEMENTS AND INTEGRATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING ARE EXPECTED TO DRIVE THE GROWTH OF THE U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET FROM 2023 TO 2030
FIGURE 12 THE SOLUTIONS SOFTWARE SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET
FIGURE 14 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY PRODUCT, 2022
FIGURE 15 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY DEPLOYMENT MODE, 2022
FIGURE 19 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
FIGURE 20 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY DEPLOYMENT MODE, CAGR (2023-2030)
FIGURE 21 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY DEPLOYMENT MODE, LIFELINE CURVE
FIGURE 22 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY MODE OF ACCESS, 2022
FIGURE 23 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY MODE OF ACCESS, 2023-2030 (USD MILLION)
FIGURE 24 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY MODE OF ACCESS, CAGR (2023-2030)
FIGURE 25 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY MODE OF ACCESS, LIFELINE CURVE
FIGURE 26 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY CODES, 2022
FIGURE 27 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY CODES, 2020-2029 (USD MILLION)
FIGURE 28 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY CODES, CAGR (2023-2030)
FIGURE 29 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY CODES, LIFELINE CURVE
FIGURE 30 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY TYPE, 2022
FIGURE 31 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 32 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 33 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY TYPE, LIFELINE CURVE
FIGURE 34 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY APPLICATION, 2022
FIGURE 35 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 36 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 37 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY PURCHASE MODE, 2022
FIGURE 39 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY PURCHASE MODE, 2023-2030 (USD MILLION)
FIGURE 40 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY PURCHASE MODE, CAGR (2023-2030)
FIGURE 41 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 42 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY END USERS, 2022
FIGURE 43 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY END USERS, 2023-2030 (USD MILLION)
FIGURE 44 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY END USERS, CAGR (2023-2030)
FIGURE 45 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY END USERS, LIFELINE CURVE
FIGURE 46 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 47 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 48 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 49 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 50 U.S. REMOTE THERAPEUTIC MONITORING (MSK) MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
